[Form 4] Kindly MD, Inc. Insider Trading Activity

Rhea-AI Filing Summary

The filing reports that Andrew Creighton, serving as Chief Compliance Officer and a director of Kindly MD, Inc. (ticker: NAKA), executed a transaction on 08/14/2025 acquiring 2,232,114 shares of the issuer's common stock at a reported price of $0. Following the reported acquisition, Mr. Creighton beneficially owns 3,124,971 shares. The Form 4 was signed by Mr. Creighton on 08/19/2025. No derivative securities were reported on this form and no additional explanatory text about the nature of the $0 price was provided in the filing.

Positive

• Large acquisition disclosed: Reporting person acquired 2,232,114 common shares on 08/14/2025.
• Increased insider ownership: Beneficial ownership rose to 3,124,971 shares after the transaction.
• Clear filing: Form 4 signed and dated by the reporting person (08/19/2025), with no derivative positions reported.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Insider acquisition materially increases the officer's stake; filing is routine but notable for size.

The report shows a large non-derivative acquisition by a senior officer who is also a director. The acquisition of 2,232,114 shares increases the reporting person's beneficial ownership to 3,124,971 shares, a substantial absolute holding disclosed on Form 4. The filing includes a reported price of $0 and contains no derivatives or additional explanatory notes, so the record is clear but lacks context about consideration or vesting. For governance review, the combination of officer and director status with this size of holding is a material disclosure for shareholders and compliance teams.

Securities Analyst

TL;DR: Large open-market disclosure of share acquisition by an insider; impact appears informational rather than immediately market-moving.

The transaction labeled with code "A" on 08/14/2025 reports the acquisition of 2,232,114 common shares at a reported price of $0, resulting in total beneficial ownership of 3,124,971 shares. The Form 4 includes no derivative positions and no amendment history. Because the form does not state the source or terms beyond the $0 price, analysts must treat this as a significant disclosure of insider holdings while recognizing the filing does not provide transaction context such as compensation grant, transfer, or clerical entry.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Creighton Andrew John

(Last) (First) (Middle)

5097 SOUTH 900 EAST, SUITE 100

(Street)

SALT LAKE CITY UT 84117

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kindly MD, Inc. [ NAKA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Compliance Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2025		A		2,232,114	A	$0	3,124,971	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Andrew Creighton	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Andrew Creighton report on the Form 4 for NAKA?

The Form 4 reports that Andrew Creighton acquired 2,232,114 shares of Kindly MD, Inc. common stock on 08/14/2025, increasing his beneficial ownership to 3,124,971 shares.

What price was reported for the shares acquired by the NAKA reporting person?

The filing shows a reported transaction price of $0 for the 2,232,114 shares acquired.

Does the Form 4 for NAKA show any derivative securities?

No. Table II for derivative securities contains no entries; the filing reports only non-derivative common stock acquisitions.

What is Andrew Creighton's role at Kindly MD as stated in the filing?

The filing identifies Andrew Creighton as a Director and an Officer with the title Chief Compliance Officer.

When was the Form 4 signed by the reporting person?

The signature block shows the Form 4 was signed by /s/ Andrew Creighton on 08/19/2025.